ライフサイエンスコーパス: neurologic complication

1 iated with mechanical, renal, pulmonary, and neurologic complications.

2 Lymphoma treatments can also cause neurologic complications.

3 ivided according to whether they experienced neurologic complications.

4 therapy but had more comorbid conditions and neurologic complications.

5 lness that causes major vascular, renal, and neurologic complications.

6 lower patient mortality without any signs of neurologic complications.

7 rocognitive outcomes in sepsis patients with neurologic complications.

8 extracorporeal membrane oxygenation-related neurologic complications.

9 iologic signs and is associated with greater neurologic complications.

10 Is) are associated with rare but devastating neurologic complications.

11 ntrol group of transplanted patients without neurologic complications.

12 ion, and Charcot-Marie Tooth disease without neurologic complications.

13 sk patients may help reduce the incidence of neurologic complications.

14 al membrane oxygenation were associated with neurologic complications.

15 een shown and is known to cause vascular and neurologic complications.

16 fluential factor that increased risk of late neurologic complications.

17 nd foramen magnum stenosis can cause serious neurologic complications.

18 edural factors significantly associated with neurologic complications.

19 There were no BA-related deaths or neurologic complications.

20 s later to cause shingles (zoster) and other neurologic complications.

21 There were no permanent neurologic complications.

22 out further systemic therapy, none with late neurologic complications.

23 ts, retrograde cerebral perfusion eliminated neurologic complications.

24 lopment and progression of microvascular and neurologic complications.

25 with sepsis, there are limited data on other neurologic complications.

26 l, 27% (95% CI, 0.17-0.39%) had at least one neurologic complication, 23% (95% CI, 0.14-0.32%) hypoxi

27 36 +/- 0.4 vs. 1.24 +/- 0.4 mg/dL, p < .02), neurologic complications (3% vs. 1.6%, p < .001), nosoco

28 The MHCA + SACP group had lower rate of neurologic complications (3/61 vs 10/53 for DHCA; p < 0.

29 C deficiency can produce the hematologic and neurologic complications after birth, whereas TCblR/CD32

30 trapontine myelinolysis (CPM/EPM) are severe neurologic complications after liver transplantation.

31 Early major neurologic complications after lung transplantation are

32 Early major neurologic complications after lung transplantation repr

33 idence that folic acid can potentially cause neurologic complications among those with low vitamin B1

34 ngs with CDG-IIb who presented with multiple neurologic complications and a paradoxical immunologic p

35 ction to acute febrile illnesses with severe neurologic complications and accounts for a significant

36 cination may prevent some SARS-CoV-2-related neurologic complications and merits further study.

37 n underscore possible concern for additional neurologic complications and nonarthropod-mediated trans

38 of life; however, the mechanisms underlying neurologic complications and their impact on outcomes in

39 outcomes will depend on better defining the neurologic complications and underlying pathophysiology

40 difference in survival between patients with neurologic complications and without (90-day mortality:

41 dorferi infection can lead to Lyme carditis, neurologic complications, and arthritis because of the a

42 e immune cells and ILCs developed arthritis, neurologic complications, and meningitis.

43 tion of extracorporeal membrane oxygenation, neurologic complications, and presence of more than thre

44 of the kynurenine pathway, the incidence of neurologic complications, and the disease outcome.

45 Neurologic complications are a major cause of morbidity

46 -cell therapy grows, distinct and infrequent neurologic complications are becoming increasingly evide

47 In-hospital neurologic complications are common in patients with sep

48 Signs and symptoms of the most common neurologic complications are described so that the clini

49 Reported influenza-associated neurologic complications are generally limited to case s

50 Even though the incidence of true neurologic complications arising from neuraxial anesthes

51 A spectrum of neurologic complications associated with COVID-19 are we

52 lighting potential mechanisms underlying the neurologic complications associated with COVID-19.

53 Neurologic complications associated with viral encephali

54 groups with respect to the rate of stroke or neurologic complications at the time of discharge (P=0.8

55 mbrane oxygenation (ECMO) is associated with neurologic complications but their impact on long-term o

56 Sixty-five percent of patients with a neurologic complication died during their hospital admis

57 (HIV) is associated with a high frequency of neurologic complications due to infection of the central

58 l leukoencephalopathy (PML) in patients with neurologic complications due to infection with human imm

59 Neurologic complications during ECMO increased the risk

60 Neurologic complications from viral infections, includin

61 Transplant recipients have a higher risk of neurologic complications from WNV infection.

62 Hepatic encephalopathy (HE) is a serious neurologic complication in patients with liver cirrhosis

63 Neurologic complications in adult patients on venoarteri

64 Background Neurologic complications in coronavirus disease 2019 (CO

65 prevalence, predictors of and survival from neurologic complications in patients who have undergone

66 Neurologic complications include diffuse cerebral ischem

67 ndently associated with an increased risk of neurologic complication included the indication of ather

68 concern, particularly given the high risk of neurologic complications (including Guillain-Barre syndr

69 s zoster can be associated with a variety of neurologic complications, including a syndrome of delaye

70 Presence or absence of neurologic complications, including delirium, was assess

71 nt association between Zika virus (ZIKV) and neurologic complications, including Guillain-Barre syndr

72 the Americas was associated with significant neurologic complications, including microcephaly of newb

73 stherpetic neuralgia, as well as with severe neurologic complications, including vasculitis and encep

74 sociated with increased morbidity, including neurologic complications, increased risk of low birth we

75 Primary influenza-associated neurologic complications (INCs) were classified into 4 g

76 over 24 hours were associated with important neurologic complications: intracranial hemorrhage, ische

77 The most frequent neurologic complication is visual field defect occurring

78 symptomatic or show mild symptoms, a risk of neurologic complications is associated with infection in

79 Patients with neurologic complications more commonly had ECMO disconti

80 Results No intraoperative neurologic complications (n = 10 [95% confidence interva

81 al fluid (CSF) diversion (n=54) and/or other neurologic complications (n=40), more than half of which

82 Neurologic complications occurred in 22 patients (39%) b

83 Neurologic complications occurred in 522 examinations (2

84 Neurologic complications occurred in 682 patients (15.1%

85 sociated dementia complex is the most severe neurologic complication of AIDS.

86 Intraventricular hemorrhage is a common neurologic complication of extremely preterm birth and l

87 To review neurologic complications of common and recently develope

88 flammatory treatment(s) in the management of neurologic complications of COVID-19 infection.

89 Neurologic complications of eclampsia are thought to be

90 Neurologic complications of herpes zoster, including chr

91 y accepted as the main mechanism involved in neurologic complications of infective endocarditis.

92 intraoperative rupture are the most frequent neurologic complications of intracranial aneurysm coilin

93 ent review summarizes common problems in the neurologic complications of leukemia and discusses recen

94 his method of treatment has no effect on the neurologic complications of liver failure and has no imp

95 Neurologic complications of lymphoid cancer can be chall

96 rticle provides an overview of the different neurologic complications of lymphoma and its treatments,

97 Our objective was to characterize the neurologic complications of M. pneumoniae in children us

98 ostvaccinal encephalomyelitis; and the known neurologic complications of monkeypox, which include hea

99 lation of gut microbiota could attenuate the neurologic complications of obesity.

100 xamined specifically for musculoskeletal and neurologic complications of Paget disease, including fra

101 flammation, in the development of post-acute neurologic complications of SARS-CoV-2 infection.

102 This was a literature review of the known neurologic complications of smallpox, which include ence

103 populations, making recognition of the many neurologic complications of this infection still relevan

104 y respiratory related, but cardiovascular or neurologic complications or exacerbations of underlying

105 nd equally importantly, careful attention to neurologic complications over time.

106 risk for death in patients with early major neurologic complications (P<0.05).

107 ient understanding of the pathophysiology of neurologic complications prevents us from addressing the

108 ion of test scores or the parents' report of neurologic complications, psychotropic drug use, and spe

109 These neurologic complications range from mild to severe acros

110 abilitation), (2) 12-month survival, and (3) neurologic complications (rebleed, delayed cerebral isch

111 rus disease 2019 (COVID-19), often result in neurologic complications, regardless of patient age.

112 nisms of neuroinflammation and correlates of neurologic complications remain elusive, especially sinc

113 ese diseases but their ability to ameliorate neurologic complications remains unclear.

114 All patients developed neurologic complications resulting from ACS episodes, in

115 The detection of neurologic complications secondary to ZIKV infection.

116 us extraintestinal manifestations, including neurologic complications such as neuropathy, ataxia, sei

117 h neonates and older children are at risk of neurologic complications, such as intracranial hemorrhag

118 er, in this communication, we report a major neurologic complication that resulted in anterior spinal

119 h mechanical, renal replacement therapy, and neurologic complications that acted as suppressing media

120 These outbreaks have been associated with neurologic complications that include congenital abnorma

121 ives, but has also created a major crisis of neurologic complications that persist even after recover

122 ar survival: 51.1% in patients who developed neurologic complication versus 62.1% in patients who did

123 day mortality: 15% of patients who developed neurologic complications versus 4% of patients who did n

124 nd their role in the pathogenesis of delayed neurologic complications warrants further investigation.

125 endently associated with a decreased risk of neurologic complication were increasing chronologic year

126 Rates of neurologic complications were analyzed, and associated f

127 Patients who experienced neurologic complications were at increased risk of death

128 Major neurologic complications were defined as those that were

129 Neurologic complications were independently associated w

130 Influenza-associated neurologic complications were observed in 4% of patients

131 Four hundred twenty-six neurologic complications were reported in 356 patients (

132 Neurologic complications were reported in 38 studies ( n

133 e mechanical, renal replacement therapy, and neurologic complications were suppressors having a negat

134 ion control, and avoidance of thromboembolic neurologic complications will be crucial to the success

135 mechanisms that plausibly account for severe neurologic complications with COVID-19 and potential tre

136 r objective was to assess the association of neurologic complications with death and new disability a

137 Seventy (9.2%) patients experienced major neurologic complications within 2 weeks after lung trans

138 Five (3.5%) patients had minor neurologic complications within 30 days (mRS = 1) (95% C

139 points included complete aneurysm occlusion; neurologic complications within 30 days and up to 3 year